a year ago
NVAX
AnalystsAlec StranahanAlec Stranahan's Stock Forecasts
AnalystsAlec Stranahan
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#4801 out of 4953 analysts
Average Return
-25.52%
Win Rate
41%9 out of 22
Risk vs Reward
Poor
Good
Alec Stranahan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Turning Point Therapeutics IncTPTX | +106.89% | $36.74 | $76.01 | 2022-05-20 - 2022-08-16 | Strong Buy |
Revolution Medicines IncRVMD | +55.46% | $28.38 | $44.12 | 2024-01-05 - 2025-01-03 | Strong Buy |
Krystal Biotech IncKRYS | +41.95% | $117.53 | $166.83 | 2023-05-22 - 2024-05-21 | Strong Buy |
Hookipa Pharma IncHOOK | +41.33% | $9.80 | $5.75 | 2022-12-02 - 2023-12-01 | Sell |
Krystal Biotech IncKRYS | +38.71% | $117.39 | $162.83 | 2023-05-25 - 2024-05-24 | Strong Buy |
Alec Stranahan Analyst Color
Get additional color on Alec Stranahan's coverage of popular stocks
a year ago
NVAX
Alec Stranahan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Novavax IncNVAX | 3 | Hold | $9.00 | +31.39% | Maintains | 9 days ago |
Krystal Biotech IncKRYS | 4 | Strong Buy | $192.00 | +25.31% | Maintains | 9 days ago |
Beam Therapeutics IncBEAM | 1 | Strong Buy | $42.00 | +108.44% | Upgrades | 4 months ago |
Y Mabs Therapeutics IncYMAB | 5 | Hold | $12.00 | +150.52% | Maintains | 5 months ago |
Candel Therapeutics IncCADL | 1 | Strong Buy | $15.00 | +128.31% | Initiates Coverage On | 6 months ago |
Day One Biopharmaceuticals IncDAWN | 4 | Strong Buy | $25.00 | +263.90% | Maintains | 7 months ago |
Caribou Biosciences IncCRBU | 1 | Strong Buy | $11.00 | +436.59% | Maintains | 7 months ago |
Erasca IncERAS | 2 | Strong Buy | $5.00 | +222.58% | Upgrades | 7 months ago |
Perspective Therapeutics IncCATX | 2 | Hold | $6.00 | +54.64% | Downgrades | 8 months ago |
Editas Medicine IncEDIT | 1 | Strong Buy | $15.00 | +495.24% | Upgrades | a year ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $55.00 | N/A | Maintains | a year ago |
Xencor IncXNCR | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 2 years ago |
Tg Therapeutics IncTGTX | 2 | Sell | $6.00 | N/A | Maintains | 3 years ago |
Hookipa Pharma IncHOOK | 1 | Sell | $5.00 | N/A | Downgrades | 3 years ago |
Springworks Therapeutics IncSWTX | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |
Turning Point Therapeutics IncTPTX | 1 | Strong Buy | $58.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.